| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6107330 | Journal of Hepatology | 2009 | 7 Pages |
Abstract
In chronic HBV infected patients, tenofovir is a cost-effective or even cost-saving strategy compared with other available treatment options for CHB.
Keywords
EASLAASLDCHBICERHBsAgHBeAgQALYHepatitis B antigenAPASLChronic hepatitis B virusHCCHepatitis B surface antigenAsian Pacific Association for the Study of the LiverAmerican Association for the Study of Liver DiseasesEuropean Association for the Study of the LiverCost-effectiveness analysisQuality-adjusted life yearsLYSMETIncremental cost-effectiveness ratiochronic hepatitis BHBVpolymerase chain reactionPCRHepatocellular carcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Maria Buti, Max Brosa, Miguel A. Casado, Magdalena Rueda, Rafael Esteban,